China Shineway Pharmaceutical Group Limited operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares China Shineway Pharmaceutical Group Limited with three other
companies in this sector in Hong Kong:
Beijing Tong Ren Tang Chinese Medicine Company Limited
sales of 1.27 billion Hong Kong Dollars [US$162.16 million]
of which 50%
was Healthcare products and Chinese medicine),
Consun Pharmaceutical Group Ltd
(1.92 billion Hong Kong Dollars [US$246.13 million]
of which 64%
was Consun Pharmaceutical), and
Yichang Hec Changjiang Pharmaceutical Co Ltd
(1.85 billion Hong Kong Dollars [US$237.43 million]
of which 100%
was Sales of pharmaceutical products).
During the year ended December of 2017, sales at
China Shineway Pharmaceutical Group Limited were HK$2.22 billion (US$284.58 million).
decrease of 4.5%
versus 2016, when the company's sales were HK$2.33 billion.
Contributing to the drop in overall sales was the 15.1% decline
in Granules, from HK$448.31 million to HK$380.54 million.
There were also decreases in sales in
Injections (down 12.2% to HK$1.14 billion)
Soft Capsules (down 2.7% to HK$412.35 million)
Others (down 12.2% to HK$139.09 million)